Wendy A Cooper
Wendy A Cooper is an expert in Oncology at Royal Prince Alfred Hospital (Australia). As of October 2026, ScienceLeadR ranks Wendy A Cooper in the top 1% of experts worldwide for Thoracic Neoplasms and Lung Neoplasms. Wendy A Cooper has authored 252 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 779 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Pulmonology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2002 - 2026
Number : 252
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Robotic left transthoracic left main bronchial sleeve resection with preoperative three-dimensional planning. PMID 42601549 — margins of excision, lung, neoplasms, pulmonary artery, carcinoid tumor | Gen Thorac Cardiovasc Surg | 2026 | 0 |
| IARC Perspective on Lung Cancer Screening. PMID 42788692 — lung, neoplasms, lung neoplasms | N Engl J Med Top journal | 2026 | 0 |
| IASLC Update on Classification of Pulmonary Neuroendocrine Neoplasms. PMID 42251892 — thoracic neoplasms, neoplasms, classification, small cell lung carcinoma, therapeutics, carcinoid tumor, carcinoma, neuroendocrine | J Thorac Oncol | 2026 | 0 |
| The 2025 ATS/ERS update of the international multidisciplinary classification of the interstitial pneumonias: implications for the pathologist. PMID 42249728 — pathologists, pathology, classification, biopsy, pulmonary fibrosis, pneumonia, idiopathic interstitial pneumonias, histology, diagnosis, lung diseases, interstitial | Histopathology | 2026 | 0 |
| Idiopathic Pulmonary Fibrosis update, comparing the Australasian Interstitial Lung Disease Registry to the Australian Idiopathic Pulmonary Fibrosis Registry. PMID 42241713 — registries, idiopathic pulmonary fibrosis, lung, fibrosis, internal medicine, immunosuppressive agents, pulmonary fibrosis, therapeutics, lung diseases, lung diseases, interstitial | Intern Med J | 2026 | 0 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 2
LeadR Networks
Main global connection map